On July 8, theEuropean Economic and Social Committee (EESC) called for steps to speed up clinical trials that include genetically modified organisms (GMOs). Some vaccines under development are based on genetically modified viruses. Current EU legislation does not take into account the possibility of speeding up clinical trials in a public health emergency. The EESC therefore welcomes a temporary adjustment of EU rules.
EESC is ready to join forces with German presidency to help find a way out of the crisis and make Europe stronger.
On 1 July, Germany picks up the baton from Croatia at the helm of the Council of the EU in what will probably be its most challenging presidency so far, with Europe facing the biggest economic, social and health crisis in its modern history.
